Home -> Law Blog Directory -> Personal Injury Law Blogs -> A Georgia Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: A Georgia LawyerErythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication
New studies have found that cancer patients and others taking this class of medications have had higher rates of tumor growth and of heart attack, heart failure, stroke or bloodclots than patients who are not on the medication. Compared with patients not on medication, patients taking the erythropoeisis-stimulating agents (or ESAs) overall have been found to die sooner as well.
Source here at the FDA site.
Full post as published by A Georgia Lawyer on March 14, 2010 (boomark / email).
Firestone Tire Problems Raise Questions of Safety
Are Your Car Tires Safe?
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Law Enforcement and Criminal Justice Career Choices
Descriptions of law enforcement occupations
FDA Issues Early Safety Communication About Meridia Diet Pill
Meridia Diet Pill FDA Issues Early Safety Communication
Xolair
FDA Issues Early Communication over Safety Data
Procrit
Associated with Death in Stroke Study
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
YTB International
Sales Agents Seek Class Action
Safety Violations
Murphy Oil USA Inc. to pay $179,100 settlement in occupational safety violations lawsuit.

Study: Anemia Drugs May Pose Death Risk
Anemia Drugs Procrit And Aranesp May Increase Twofold The Risk Of Potentially Fatal Blood Clots
Aranesp , Epogen, and Procrit Linked to Increased Tumor Growth
Anemia Drugs Given Stronger Warnings
Anemia Drugs Under FDA Scrutiny Again
Aranesp, Procrit problems continue to mount








